Reliable and willing to make themselves available for the duration of the study and are willing to follow study-specific procedures.
Available for follow up
Reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Patients must be accessible for treatment and follow-up. Investigators must assure themselves the patients randomized on this trial will be available for complete documentation of the treatment, adverse events, and follow-up
Patients not expected to be available for follow-up for at least  days after transplant
Must be available during the duration of the study and willing to follow the study procedures
Patient must be available for follow-up
Available for long-term follow-up of their disease after treatment
Available for the whole duration of the study
Patients must be, in the opinion of the Investigator, available and compliant for treatment and follow-up.
Available for the duration of the study and are willing to follow study-specific procedures.
Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Patient must be available for follow-up; after  years of follow-up following post-treatment biopsy, telephone-based follow-up will be acceptable
Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Patients who in the opinion of the Investigator would not be able to provide reliable study data or be available for study follow-up
Patients must be accessible for treatment and follow-up; investigators must assure themselves the patients randomized on this trial will be available for complete documentation of the treatment, adverse events, and follow-up
Reliable and available for the duration of the study and willing to follow study procedures.
Patients not available for follow-up testing
Patients not available for follow-up tests
Patient must still be in active follow-up: seen for a follow-up visit in the participating center at least once in the  years prior to enrollment and/or scheduled to be seen for follow-up in the next  months (i.e. in active follow-up)
Patients who are not expected to be available for follow-up in our institution for at least  days after the transplant
Subject will not be available for follow-up assessment
Available for follow-up over the course of the study;
Not available for follow-up over the course of the study;
Available for duration of study
Available for duration of study
Agree to participate in the study and be available for  weeks of treatment and  months of follow-up
Patient must be available for follow-up